Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,608 | 968 | 811 | 894 | 896 |
| Cost of Goods | 218 | 141 | 136 | 147 | 140 |
| Gross Profit | 1,390 | 827 | 676 | 747 | 756 |
| Operating Expenses | 3,349 | 2,685 | 2,912 | 2,612 | 3,191 |
| Operating Income | -1,741 | -1,717 | -2,100 | -1,718 | -2,295 |
| Interest Expense | 26 | 29 | 60 | 13 | 2 |
| Other Income | 6 | 37 | 37 | 41 | 19 |
| Pre-tax Income | -1,761 | -1,709 | -2,123 | -1,690 | -2,279 |
| Net Income Continuous | -1,761 | -1,709 | -2,123 | -1,690 | -2,279 |
| Net Income | $-1,761 | $-1,709 | $-2,123 | $-1,690 | $-2,279 |
| EPS Basic Total Ops | -0.18 | -0.16 | -0.24 | -0.22 | -0.33 |
| EPS Basic Continuous Ops | -0.16 | -0.14 | -0.21 | -0.20 | -0.31 |
| EPS Diluted Total Ops | -0.18 | -0.16 | -0.24 | -0.22 | -0.33 |
| EPS Diluted Continuous Ops | -0.16 | -0.14 | -0.21 | -0.20 | -0.31 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.17 | -0.24 | -0.22 | -0.31 |
| EBITDA(a) | $-1,724 | $-1,693 | $-2,084 | $-1,705 | $-2,289 |